Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sichuan Ren'an Pharmaceutical is a prominent Chinese pharmaceutical manufacturer and a key subsidiary of the Kelun Pharmaceutical Group. The company specializes in the development and large-scale production of high-end Active Pharmaceutical Ingredients (APIs) and chemical intermediates, with a particular global reputation for carbapenem antibiotics. Operating out of a major production base in Guang'an, Sichuan, the company maintains rigorous GMP standards and has successfully passed inspections from international regulatory bodies including the US FDA and EDQM. Its diverse product line supports therapeutic areas such as anti-infectives, cardiovascular health, and diabetes management. Ren'an Pharmaceutical plays a vital role in Kelun's vertical integration strategy, ensuring a stable supply of high-quality raw materials for both domestic and international pharmaceutical markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sichuan Ren'an Pharmaceutical.